Biorce closes €3.5m round led by YZR Capital and Mustard Seed

by Biorce

20 days ago
Biorce, clinical trials, artificial intelligence, YZR Capital, Mustard Seed

Biorce, a Barcelona based TechBio company dedicated to transforming clinical trials through artificial intelligence, has announced the successful completion of a €3.5 million funding round. The inve...

The voice of patients as a driving force in clinical trials

by Vall d’Hebron

1 month ago
PROMs, clinical trials

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

Clinical trials: the patient's perspective

by Sermes CRO

2 years ago
Clinical trials

From the beginning of the development of any drug until it is available to patients and health professionals, its safety and efficacy must be studied and demonstrated. That is exactly what clinical t...

Spain leads research in advanced therapies with almost 120 clinical trials

by Asebio

4 years ago
advanced therapies, cancer, clinical trials

Spain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of diseases such as cancer, where 62% of clinical trials are conducted.

The importance of registering and posting clinical trials in a public database

by AKRN Scientific Consulting

4 years ago
clinical studies, clinical trials, Eudamed databank, public database, register clinical trial

Clinical investigations, commonly referred to as clinical trials, play a pivotal role both in developing new treatments and in detecting, diagnosing, and reducing the progression of disease con...

ORYZON to present further positive efficacy data from iadademstat ALICE Phase IIa trial at the 62nd Congress of the American Society of Hematology

by Oryzon Genomics

4 years ago
clinical trials, epigenetics, ORYZON, ALICE, iadademstat

ORYZON to present further positive efficacy data from iadademstat ALICE Phase IIa trial at the 62nd Congress of the American Society of Hematology

VHIO researchers describe the relevance of molecular selection in a new era of clinical trials

by Vall d’Hebron

4 years ago
VHIO, clinical trials, molecular selection, DIAMAV

Early identification of the molecular characteristics of tumors in cancer patients is gaining increasing relevance in the development of anti-cancer therapies. Early molecular profiling influences the...

The health department will finance 3 IDIBELL’s projects on COVID-19

by Hospital Universitari de Bellvitge

5 years ago
therapies, clinical trials, Health, covid-19

The Department of Health, through the General Direction fo Research and Innovation in Health (DGRI) and in collaboration with Biocat, will finance with 4 million euros a total of 19 research and innov...

Pivotal Acquires Akcelis, an Industry Leader in Patient Engagement, Recruitment and Retention

by Pivotal

5 years ago
Akcelis, clinical trials, recruitment, patients, biofarmaceutics

Pivotal announced today the acquisition of Akcelis BVBA, a leading full-service provider of patients´ enrollment and retention solutions for clinical trials in the life sciences´ industry.

Sant Joan de Déu seeks young patients and caregivers to create the first pediatric expert patient database

by Fundació Sant Joan de Déu

5 years ago
platform, pediatrics, clinical trials, young patients, caregivers

People registered on this platform will help to include the vision of patients in the process of developing clinical trials in pediatrics.

Collection and Management of Concomitant Medications in Clinical Trials

by Syntax for Science S.L

5 years ago
good practices, medications, food supplements, clinical trials, effects

On some occasions sponsors and investigators might challenge the need to collect concomitant medications during clinical trials. In this article, we briefly summarize the importance and the most exten...

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer

by Pivotal

6 years ago
Pivotal, clinical trials, drug, melanoma, lung cancer

Pivotal, a specialist CRO, has been awarded two clinical trials for a novel investigational immunotherapy drug and patient enrolment has now started. Pivotal will use its deep knowledge of Oncology...